"Canada is the first country to approve Sativex®. The Health Protection Branch has granted the drug a Notice of Compliance with conditions (NOCc). NOCcs are granted for drugs with promising benefit and acceptable safety profiles.
Because of the conditions, Bayer must submit further data from clinical trials to Health Canada before the conditions will be removed.
As to Europe, I don't care.